Wire · regulatory
Bayer Secures FDA Nod For SUNHARBO In Secondary Stroke Prevention
◆ Sectors
Biotech
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 10 November 2026 · Fusion42 review
Bayer has received FDA approval for SUNHARBO for use in secondary stroke prevention, marking an important regulatory milestone for the drug.
This Wire brief sits within Fusion42's coverage of Biotech, and 3 sources have reported it.
◆ ◆ The Wire takeaway
You can now explore FDA-approved stroke prevention options involving Bayer's SUNHARBO, opening new treatment pathways and market opportunities in the US biotech space.
◆ Coverage
3 sources · 10 Nov 2026
◆ Related on Wire
◆ Topics
Biotechfda-approvalstroke-preventiondrug-regulationbayer